Related Experiment Video
Updated: Apr 13, 2026

10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
7.1K
Partial PFO Closure for Persistent Hypoxemia in a Patient with Ebstein Anomaly
S A Zuberi1, S Liu2, J W Tam2
1Department of Internal Medicine, Faculty of Medicine, University of Manitoba, 409 Tache Avenue, Winnipeg, MB, Canada R2H 2A6.
Case Reports in Cardiology
|May 7, 2015
Summary
Ebstein anomaly patients with severe tricuspid regurgitation and patent foramen ovale dependency may benefit from partial closure. Complete closure can cause decompensation, while partial closure improves hemodynamic stability and oxygenation.
Area of Science:
- Cardiology
- Congenital Heart Disease
Background:
- Ebstein anomaly involves tricuspid valve deformities and right ventricle atrialization.
- Severe tricuspid regurgitation often necessitates tricuspid valve surgery and atrial septal defect closure.
Purpose of the Study:
- To evaluate the impact of patent foramen ovale closure in a patient with Ebstein anomaly and severe hypoxemia.
- To determine the optimal closure strategy for a patent foramen ovale in the context of Ebstein anomaly and right-to-left shunting.
Main Methods:
- Case presentation of a 73-year-old female with Ebstein anomaly and severe hypoxemia.
- Transthoracic echocardiography to assess tricuspid regurgitation and patent foramen ovale with right-to-left shunting.
- Percutaneous closure of the patent foramen ovale, initially complete then partial.
Main Results:
- Complete percutaneous patent foramen ovale closure resulted in acute decompensation.
- Partial closure of the patent foramen ovale led to hemodynamic stability and improved oxygenation.
- The patient demonstrated "patent foramen ovale dependency" due to longstanding shunts.
Conclusions:
- Partial patent foramen ovale closure can be a beneficial strategy for selected Ebstein anomaly patients with "patent foramen ovale dependency".
- Careful consideration of closure extent is crucial to avoid adverse events in patients with complex congenital heart disease.
Related Concept Videos
Mitral Stenosis I: Introduction
1.5K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.5K
Mitral Stenosis III: Medical Management
483
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
483
Pulmonary Hypertension: Classification and Pathogenesis
880
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
880

